Table 1.
Electrophysiological findings
| MNCV, m/s (normal values) |
Distal latency, ms (normal values) |
CMAPs, mV (normal values) |
Sensory amplitude, µV (SNAPs) (normal values) |
||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| median | ulnar | peroneal | median | ulnar | peroneal | median | ulnar | peroneal | median | sural | |
| Time after drug intake | |||||||||||
| 28 days | R: 32.2 | R: 36.2 | R: 0 | R: 5.21 | R: 4.51 | R: 6.40 | R: 0.7 | R: 0.2 | R: 0 | R: 9.92 | R: 0 |
| L: 36.2 (51.1±3.7) |
L: 37.2 (52.4±3.5) |
L: 0 (48.3±3.9) |
L: 7.23 (1.82±0.19) |
L: 4.53 (3.7±0.2) |
L: 6.11 (3.9±0.8) |
L: 0.5 (6±2.2) |
L: 0.2 (52.5±3.8) |
L: 0 (4.5±2.7) |
L: 7.73 (24.4±3.3) |
L: 0 (23.6±3.5) |
|
| 2 months | R: 32.2 | R: 32.2 | R: 32.2 | R: 5.21 | R: 4.23 | R: 4.63 | R: 0.7 | R: 0.2 | R: 0.64 | R: 14.94 | R: 0 |
| L: 36.2 (51.1±3.7) |
L: 36.2 (52.4±3.5) |
L: 36.2 (48.3±3.9) |
L: 7.23 (1.82±0.19) |
L: 4.14 (3.7±0.2) |
L: 5.21 (3.9±0.8) |
L: 0.5 (6±2.2) |
L: 0.2 (52.5±3.8) |
L: 0.48 (4.5±2.7) |
L: 12.65 (24.4±3.3) |
L: 0 (23.6±3.5) |
|
| 6 months | R: 50.17 | R: 32.2 | R: 32.2 | R: 5.21 | R: 3.56 | R: 3.56 | R: 0.7 | R: 0.2 | R: 0.64 | R: 35.9 | R: 0 |
| L: 36.2 (51.1±3.7) |
L: 36.2 (52.4±3.5) |
L: 36.2 (48.3±3.9) |
L: 7.23 (1.82±0.19) |
L: 3.52 (3.7±0.2) |
L: 3.71 (3.9±0.8) |
L: 0.5 (6±2.2) |
L: 0.2 (52.5±3.8) |
L: 0.48 (4.5±2.7) |
L: 34.3 (24.4±3.3) |
L: 0 (23.6±3.5) |
|
MNCV, motor nerve conduction velocity; SNAPs, sensory nerve action potentials; R, right; L, left.